Viewing Study NCT04929392

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:28 PM
Ignite Modification Date: 2026-02-20 @ 5:56 PM
Study NCT ID: NCT04929392
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-04
First Post: 2021-06-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer
Sponsor: City of Hope Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Esophageal Adenocarcinoma View
None Esophageal Squamous Cell Carcinoma View
None Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 View
None Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 View
Keywords: